export type BlogSection = {
  heading: string;
  paragraphs: string[];
};

export type BlogPost = {
  slug: string;
  title: string;
  excerpt: string;
  category: string;
  readTime: string;
  date: string;
  publishedAt: string;
  intro: string;
  sections: BlogSection[];
};

export const blogPosts: readonly BlogPost[] = [
  {
    slug: "what-are-peptides",
    title: "What Are Peptides? A Beginner's Guide to Bioregulators",
    excerpt:
      "Peptides are short chains of amino acids that act as biological messengers in the body. Learn how they differ from proteins, why they're gaining traction in health optimization, and what the research actually says.",
    category: "Education",
    readTime: "6 min read",
    date: "March 2025",
    publishedAt: "2025-03-10",
    intro:
      "Peptides are short chains of amino acids that help regulate communication inside the body. They have become a major topic in health optimization because some peptides act as precise biological signals rather than broad-spectrum interventions.",
    sections: [
      {
        heading: "What Peptides Are",
        paragraphs: [
          "Proteins and peptides are made from the same building blocks, but peptides are shorter and often more targeted in the way they interact with receptors. That smaller size can make them easier to synthesize and easier to study in focused pathways.",
          "Many naturally occurring peptides already exist inside the human body. Insulin, oxytocin, and several growth-hormone signaling compounds are familiar examples of peptides that already have defined biological roles.",
        ],
      },
      {
        heading: "How Peptides Work",
        paragraphs: [
          "Most peptides act like messengers. They bind to specific receptors and trigger downstream responses related to appetite, tissue repair, inflammation, sleep, cognition, or hormone signaling.",
          "That specificity is one reason peptides attract so much interest. A good peptide profile is less about vague wellness language and more about the exact pathway being influenced.",
        ],
      },
      {
        heading: "Why the Category Is Growing",
        paragraphs: [
          "The success of GLP-1 medications made peptide-based interventions feel more tangible to the mainstream. At the same time, the research peptide market grew quickly, which brought both real scientific curiosity and a lot of marketing noise.",
          "That combination is why independent education matters. Some compounds are clinically established, while others remain preclinical or highly anecdotal.",
        ],
      },
      {
        heading: "What the Evidence Usually Looks Like",
        paragraphs: [
          "For many well-known research peptides, the majority of evidence still comes from animal studies or mechanistic lab research. That does not make the science meaningless, but it does mean claims need to be framed more carefully than many vendor pages suggest.",
          "The right question is rarely 'does this peptide sound promising?' It is usually 'what kind of evidence exists, and what level of uncertainty still remains?'",
        ],
      },
      {
        heading: "PeptidePilot Assessment",
        paragraphs: [
          "Peptides are a legitimate area of scientific and clinical interest, but they are not one single category with one evidence standard. A responsible approach separates clinically established therapies from research compounds and keeps the sourcing, safety, and supervision conversation in view.",
        ],
      },
    ],
  },
  {
    slug: "bpc157-complete-guide",
    title: "BPC-157: The Complete Guide to Body Protection Compound",
    excerpt:
      "BPC-157 has become one of the most widely discussed peptides in the recovery and injury-healing space. We break down the preclinical evidence, proposed mechanisms, and what users typically report.",
    category: "Peptide Profiles",
    readTime: "9 min read",
    date: "February 2025",
    publishedAt: "2025-02-14",
    intro:
      "BPC-157 is a synthetic pentadecapeptide derived from a protein found in human gastric juice. It is one of the most talked-about recovery peptides because of its unusually broad preclinical literature and its heavy presence in musculoskeletal and gut-health conversations.",
    sections: [
      {
        heading: "Mechanism of Action",
        paragraphs: [
          "BPC-157 appears to interact with several pathways tied to tissue repair, including nitric oxide signaling, fibroblast activity, and angiogenesis. That is one reason it appears so frequently in tendon, ligament, and wound-healing discussions.",
          "Some researchers also focus on its potential gut-protective effects, which is why it shows up in digestive-health communities as often as it does in sports medicine circles.",
        ],
      },
      {
        heading: "The Evidence Base",
        paragraphs: [
          "The strongest BPC-157 evidence is still preclinical. Animal studies have repeatedly shown promising signals for tendon healing, ligament recovery, muscle repair, and gastrointestinal protection.",
          "What remains limited is large-scale human clinical evidence. That gap is important, because many people encounter BPC-157 through marketing language that sounds more definitive than the human data allows.",
        ],
      },
      {
        heading: "Common Applications",
        paragraphs: [
          "The most common user interest clusters around joint pain, tendon strain, post-training recovery, soft-tissue healing, and gut-barrier support. Those use cases are heavily shaped by anecdotal momentum and preclinical plausibility rather than settled clinical consensus.",
        ],
      },
      {
        heading: "Administration",
        paragraphs: [
          "BPC-157 is commonly discussed in subcutaneous injectable protocols, especially near the area of concern, although oral forms are often mentioned for gut-focused goals. Protocol details vary widely and should never be copied casually across different contexts.",
        ],
      },
      {
        heading: "Safety Profile",
        paragraphs: [
          "The anecdotal safety reputation of BPC-157 is relatively favorable, but that should not be confused with comprehensive human safety data. The bigger practical concerns often come from sourcing, sterility, and the overall gray-market environment around research compounds.",
        ],
      },
      {
        heading: "PeptidePilot Assessment",
        paragraphs: [
          "BPC-157 remains one of the most compelling recovery compounds in the research peptide space, but it should be approached with a clear understanding of the evidence ceiling. The scientific interest is real; the human certainty is not.",
        ],
      },
    ],
  },
  {
    slug: "glp1-peptides-explained",
    title: "GLP-1 Peptides Explained: Semaglutide, Tirzepatide, and the Metabolic Revolution",
    excerpt:
      "The GLP-1 class of peptides has transformed the conversation around metabolic health and weight management. Here's what the clinical data actually shows — and what it doesn't.",
    category: "Metabolic Health",
    readTime: "11 min read",
    date: "January 2025",
    publishedAt: "2025-01-18",
    intro:
      "GLP-1-based therapies changed the public conversation around metabolic health because they combine appetite regulation, glycemic improvement, and meaningful outcome data in ways older categories often did not.",
    sections: [
      {
        heading: "Why GLP-1 Therapies Matter",
        paragraphs: [
          "Semaglutide and tirzepatide are not just trending names; they sit on top of a substantial clinical evidence base. That makes them very different from research compounds that are still largely discussed in preclinical or anecdotal terms.",
          "They matter because they moved peptide-based intervention out of niche longevity circles and into mainstream medical treatment.",
        ],
      },
      {
        heading: "Semaglutide vs Tirzepatide",
        paragraphs: [
          "Semaglutide works through GLP-1 receptor activity alone, while tirzepatide combines GIP and GLP-1 receptor activity. That mechanistic difference is part of why tirzepatide is often framed as a stronger efficacy option in some settings.",
          "The actual choice between them still depends on side-effect tolerance, clinical support, pricing, and the care model behind the prescription.",
        ],
      },
      {
        heading: "What the Data Shows",
        paragraphs: [
          "The strongest clinical results usually center on appetite regulation, weight reduction, improved glycemic markers, and better metabolic control. These are not speculative outcomes; they are central to why the category became so widely adopted.",
        ],
      },
      {
        heading: "Where the Conversation Gets Distorted",
        paragraphs: [
          "Online marketing often compresses GLP-1 care into before-and-after promises without talking about dose escalation, contraindications, sourcing, or what ongoing monitoring should look like. The molecule matters, but the program matters too.",
        ],
      },
      {
        heading: "PeptidePilot Assessment",
        paragraphs: [
          "GLP-1 and related incretin therapies deserve to be treated as a clinical-care category, not as just another corner of the research peptide market. The evidence is strong, but the quality of supervision still changes the real-world outcome.",
        ],
      },
    ],
  },
  {
    slug: "peptides-for-sleep",
    title: "Peptides for Sleep: DSIP, Epithalon, and the Science of Restorative Rest",
    excerpt:
      "Poor sleep is one of the most common complaints we see in quiz responses. Several peptides have demonstrated meaningful effects on sleep architecture. Here's what the evidence shows.",
    category: "Sleep & Recovery",
    readTime: "7 min read",
    date: "December 2024",
    publishedAt: "2024-12-08",
    intro:
      "Sleep-related peptide research is attractive because it aims at architecture and recovery quality, not just sedation. That makes the category especially interesting for people who feel tired but do not want another blunt sleep aid.",
    sections: [
      {
        heading: "The Main Compounds People Research",
        paragraphs: [
          "DSIP and Epithalon appear frequently in sleep and circadian-health conversations. They are usually discussed for their potential relationship to sleep depth, rhythm quality, and overnight restoration rather than for knockout-style sedation.",
        ],
      },
      {
        heading: "What Better Sleep Actually Means",
        paragraphs: [
          "Most people say they want better sleep when what they really mean is deeper recovery, fewer wake-ups, lower evening stress, or better next-day energy. That distinction matters because the most relevant compound often depends on the exact problem being solved.",
        ],
      },
      {
        heading: "Evidence Limits",
        paragraphs: [
          "Compared with metabolic therapies, the evidence base here is thinner and more uneven. Some mechanisms are plausible and some user reports are strong, but clinical certainty is not the same thing as intrigue.",
        ],
      },
      {
        heading: "How PeptidePilot Frames the Category",
        paragraphs: [
          "Sleep peptides belong in a careful, context-heavy discussion. They may be useful in certain profiles, but they should be evaluated alongside light exposure, stress load, caffeine intake, recovery demands, and other foundational sleep variables.",
        ],
      },
    ],
  },
  {
    slug: "how-to-source-peptides-safely",
    title: "How to Source Peptides Safely: What to Look For in a Vendor",
    excerpt:
      "The peptide market is largely unregulated, which means quality varies enormously. This guide covers the key markers of a trustworthy vendor — from third-party testing to certificate of analysis standards.",
    category: "Sourcing Guide",
    readTime: "8 min read",
    date: "November 2024",
    publishedAt: "2024-11-16",
    intro:
      "The sourcing question is one of the most important parts of peptide safety because even a promising compound becomes a bad decision when the sterility, identity, or handling standards are unclear.",
    sections: [
      {
        heading: "What Good Vendors Explain Clearly",
        paragraphs: [
          "Trustworthy vendors make it easy to understand what was tested, what the certificate of analysis actually means, and how sterile handling is addressed. Clarity is part of the quality signal.",
        ],
      },
      {
        heading: "How COAs Get Misused",
        paragraphs: [
          "A certificate of analysis can be helpful, but it is not magic. People often treat any COA as proof that a product is reliable, even when the testing is incomplete, outdated, or disconnected from the exact batch they are buying.",
        ],
      },
      {
        heading: "The Biggest Red Flags",
        paragraphs: [
          "Be skeptical of miracle claims, vague sourcing language, no testing context, or vendors that lean entirely on influencer trust. Those are marketing shortcuts, not quality controls.",
        ],
      },
      {
        heading: "PeptidePilot Assessment",
        paragraphs: [
          "In the peptide world, source quality is not a side issue. It is part of the intervention itself. Any serious decision should treat sourcing, sterility, and transparency as first-order variables.",
        ],
      },
    ],
  },
  {
    slug: "cognitive-peptides-selank-semax",
    title: "Selank and Semax: The Nootropic Peptides Backed by Decades of Research",
    excerpt:
      "Developed in Russia and studied extensively for their cognitive and anxiolytic properties, Selank and Semax remain among the most evidence-backed options for mental performance and stress resilience.",
    category: "Cognition",
    readTime: "10 min read",
    date: "October 2024",
    publishedAt: "2024-10-11",
    intro:
      "Selank and Semax stand out in nootropic peptide conversations because they are discussed for both cognitive performance and mood regulation, which makes them especially relevant for people whose focus problems are tied to anxiety or stress.",
    sections: [
      {
        heading: "Why They Are Grouped Together",
        paragraphs: [
          "Selank and Semax are often paired because they seem to address overlapping but not identical needs. Selank is commonly discussed for anxiety modulation and emotional steadiness, while Semax tends to show up in conversations about focus, drive, and cognitive output.",
        ],
      },
      {
        heading: "What Makes Them Distinct",
        paragraphs: [
          "The useful question is not whether one is 'better' overall. It is whether the user needs calmer cognition, sharper task performance, better stress resilience, or a balance of all three.",
        ],
      },
      {
        heading: "The Evidence Conversation",
        paragraphs: [
          "These compounds have a more established research history than many gray-market peptides, but they still deserve the same caution around source quality, exaggeration, and overconfident claims.",
        ],
      },
      {
        heading: "PeptidePilot Assessment",
        paragraphs: [
          "Selank and Semax remain among the more serious entries in the cognitive-peptide world, especially when anxiety, focus, and stress overlap. They should still be evaluated with the same evidence discipline as any other compound class.",
        ],
      },
    ],
  },
] as const;

export function getBlogPost(slug: string) {
  return blogPosts.find((post) => post.slug === slug);
}
